<p>Cells were incubated in medium 5% FCS in the presence of increasing concentrations of SC560 or SC236 (1–100 nM); 10 min after treatment with inhibitors, cells were added with arachidonic acid (10 µM) and EGCG (100 µM) for 30 min. PGI<sub>2</sub> was evaluated as 6-keto-PGF<sub>1α</sub> in aliquots of cell supernatants using a specific EIA. Values are expressed as pg/ml ± SE (<i>n</i> = 3) of 6-keto-PGF<sub>1α</sub>. # P<0.01 vs AA alone; *<i>P</i><0.05, **<i>P</i><0.01 <i>vs.</i> (AA+EGCG).</p
<p>Experimentally, COX2 inhibition can be achieved through treatment of cells with exogenous competi...
<p>(A–F) CRFK and RAW264.7 cells were treated with a selective COX-1 inhibitor (SC-560), a selective...
<p>(<b>A</b>) NPC cells were pretreated with lipopolysaccharides (LPS) (2 µg/ml) for 8 hours then tr...
<p>Cells were incubated in medium 5% FCS in the presence of increasing concentrations of SC560 or SC...
<p>(A–D), SW480 and LoVo cells were treated with UA for 48 h. The expression of COX-2 protein (<b>A<...
<p>A) IEC-6 cells were treated with the indicated concentrations of LPS for 24 hours. B) IEC-6 cells...
<p>(A) A549 cells were incubated with NS-398 (50 µM) for 3 days and the cell cycle was analyzed as d...
<p>A. COX-2 deficiency enhanced the ratio of thromboxane B<sub>2</sub> to 6-keto prostaglandin F<sub...
<p>(A) Expression of COX-2 protein was detected by immunoblotting as described in Materials and Meth...
<p>IEC-6 cells were treated with LPS (2 µg/mL) for 48 hours in the presence or absence of A) Celecox...
<p>(<b>A</b>) Treatment of A375 and Hs294t cells with EGCG for 24 h resulted in down-regulation of C...
<p>BMDM were pretreated with COX-2-selective inhibitor NS-398 (20 µM, 0.5 hr) prior to the treatment...
<p>A) IEC-6 cells were treated with LPS (2 µg/mL) for 15 minutes or with EGF (10 ng/mL) for 5 minute...
groups (at the 2- and 5-positions). The listed COX-2 inhibitory potency (IC50) of these compounds is...
<p>A) EGF-driven cell proliferation was assayed in cells growing in the presence of EGF (100 ng/ml) ...
<p>Experimentally, COX2 inhibition can be achieved through treatment of cells with exogenous competi...
<p>(A–F) CRFK and RAW264.7 cells were treated with a selective COX-1 inhibitor (SC-560), a selective...
<p>(<b>A</b>) NPC cells were pretreated with lipopolysaccharides (LPS) (2 µg/ml) for 8 hours then tr...
<p>Cells were incubated in medium 5% FCS in the presence of increasing concentrations of SC560 or SC...
<p>(A–D), SW480 and LoVo cells were treated with UA for 48 h. The expression of COX-2 protein (<b>A<...
<p>A) IEC-6 cells were treated with the indicated concentrations of LPS for 24 hours. B) IEC-6 cells...
<p>(A) A549 cells were incubated with NS-398 (50 µM) for 3 days and the cell cycle was analyzed as d...
<p>A. COX-2 deficiency enhanced the ratio of thromboxane B<sub>2</sub> to 6-keto prostaglandin F<sub...
<p>(A) Expression of COX-2 protein was detected by immunoblotting as described in Materials and Meth...
<p>IEC-6 cells were treated with LPS (2 µg/mL) for 48 hours in the presence or absence of A) Celecox...
<p>(<b>A</b>) Treatment of A375 and Hs294t cells with EGCG for 24 h resulted in down-regulation of C...
<p>BMDM were pretreated with COX-2-selective inhibitor NS-398 (20 µM, 0.5 hr) prior to the treatment...
<p>A) IEC-6 cells were treated with LPS (2 µg/mL) for 15 minutes or with EGF (10 ng/mL) for 5 minute...
groups (at the 2- and 5-positions). The listed COX-2 inhibitory potency (IC50) of these compounds is...
<p>A) EGF-driven cell proliferation was assayed in cells growing in the presence of EGF (100 ng/ml) ...
<p>Experimentally, COX2 inhibition can be achieved through treatment of cells with exogenous competi...
<p>(A–F) CRFK and RAW264.7 cells were treated with a selective COX-1 inhibitor (SC-560), a selective...
<p>(<b>A</b>) NPC cells were pretreated with lipopolysaccharides (LPS) (2 µg/ml) for 8 hours then tr...